Blue Owl Capital Holdings LP
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 11, 2025), Blue Owl Capital Holdings LP reported 46 stock positions worth $308.2 million. Its top holding was Nuveen Churchill Direct Lend (NCDL) at 21.2% of the portfolio, followed by Blue Owl Capital (OBDC, 9.5%) and Cullinan Therapeutics (CGEM, 5.8%). Compared with Q1 2025, it opened 10 new positions, sold out of 9, added to 6 and reduced 12. The biggest buy was a new position in Tempus AI Class A (TEM) and the biggest sale an exit from Proshares Ultrapro QQQ (TQQQ).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001858703
- Portfolio Value
- $308.2M (Q2 2025)
- SEC Filing
- 0000950123-25-007440 ↗ filed Aug 11, 2025
Holdings Value
Holdings 46 stocks · $308.2M
| NCDL Nuveen Churchill Direct Lend | 21.22% | 4,039,553 | $65.4M | No change |
| OBDC Blue Owl Capital Corp. | 9.51% | 2,045,070 | $29.3M | No change |
| CGEM Cullinan Therapeutics Inc. | 5.83% | 2,385,972 | $18.0M | Reduce -2.0% |
| EVCM Evercommerce Inc. | 5.59% | 1,641,929 | $17.2M | No change |
| TRML Tourmaline Bio Inc. | 5.17% | 997,107 | $15.9M | Reduce -3.9% |
| LRMR Larimar Therapeutics Inc. | 4.62% | 4,928,040 | $14.2M | Add +3.1% |
| ENGN Engene Holdings Inc. | 4.40% | 3,728,106 | $13.6M | Add +13.7% |
| CNDT Conduent Inc. | 3.82% | 4,456,848 | $11.8M | Reduce -21.8% |
| SGMT Sagimet Biosciences Inc. Class A | 3.28% | 1,328,351 | $10.1M | No change |
| RARE Ultragenyx Pharmaceutical Inc. | 3.01% | 255,238 | $9.3M | Add +66.6% |
| HLLY Holley Inc. | 2.67% | 4,112,361 | $8.2M | Reduce -22.7% |
| CVEO Civeo Corp. | 2.38% | 317,411 | $7.3M | Reduce -8.8% |
| CMPX Compass Therapeutics Inc. | 2.19% | 2,591,525 | $6.7M | Reduce -12.3% |
| IRON Disc Medicine Inc. | 2.10% | 122,260 | $6.5M | Reduce -12.8% |
| IKENA ONCOLOGY INC | 1.78% | 4,091,118 | $5.5M | No change |
| EYPT Eyepoint Inc. | 1.72% | 562,594 | $5.3M | Reduce -29.5% |
| TEM Tempus AI Inc. Class A | 1.65% | 80,167 | $5.1M | New |
| CNTX Context Therapeutics Inc. | 1.57% | 7,407,906 | $4.9M | Add +0.5% |
| RPTX Repare Therapeutics Inc. | 1.55% | 3,443,659 | $4.8M | No change |
| MLYS Mineralys Therapeutics Inc. | 1.47% | 335,944 | $4.5M | Add +62.9% |
| CNTA Centessa Pharmaceuticals Ltd. | 1.41% | 330,600 | $4.3M | Add +5.0% |
| TNGX Tango Therapeutics Inc. | 1.35% | 814,416 | $4.2M | Reduce -61.6% |
| ELDN Eledon Pharmaceuticals Inc. | 1.17% | 1,329,912 | $3.6M | Reduce -26.9% |
| PLRX Pliant Therapeutics Inc. | 1.12% | 2,969,199 | $3.4M | No change |
| AQST Aquestive Therapeutics Inc. | 0.99% | 920,000 | $3.0M | No change |
| PVLA Palvella Therapeutics Inc. | 0.92% | 125,259 | $2.8M | Reduce -10.7% |
| STWD Starwood Property Trust Inc. | 0.86% | 131,461 | $2.6M | New |
| DELL Dell Technologies -C | 0.83% | 20,848 | $2.6M | New |
| BMEA Biomea Fusion Inc. | 0.76% | 1,300,000 | $2.3M | New |
| ADCT Adc Therapeutics SA | 0.64% | 733,568 | $2.0M | No change |
| FLD Fold Holdings Inc. filed as FOLD HLDGS INC | 0.62% | 856,632 | $1.9M | New |
| VRNA Verona Pharma Ltd. | 0.56% | 18,347 | $1.7M | No change |
| CABA Cabaletta Bio Inc. | 0.55% | 1,125,000 | $1.7M | New |
| KRRO Korro Bio Inc. | 0.51% | 125,000 | $1.6M | New |
| APGE Apogee Therapeutics Inc. | 0.49% | 35,000 | $1.5M | New |
| TTAN Servicetitan Inc. Class A | 0.39% | 11,350 | $1.2M | New |
| EPD Enterprise Products Partners | 0.31% | 31,290 | $970K | No change |
| MRKR Marker Therapeutics Inc. | 0.28% | 554,250 | $848K | No change |
| CMPS Compass Pathways PLC | 0.21% | 229,914 | $644K | Reduce -79.8% |
| RZLV Rezolve AI PLC | 0.18% | 181,667 | $559K | No change |
| ALPHA MODUS HLDGS INC | 0.14% | 394,078 | $418K | No change |
| CAH Cardinal Health Inc. | 0.09% | 1,718 | $289K | No change |
| SHFS SHF Holdings Inc. | 0.05% | 75,897 | $165K | No change |
| AEON Aeon Biopharma Inc. | 0.01% | 42,353 | $32K | No change |
| ENGENE HOLDINGS INC | 0.01% | 36,100 | $30K | No change |
| KPLT Katapult Holdings Inc. | 0.00% | 5,421 | $7K | New |
Other holdings (26): bonds, preferreds, convertibles and warrants · $1.6M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | 476,685 | $381K | Reduce -21.0% |
| SLND.WS Legato Merger Corp. II -CW23 | *W EXP 02/14/202 | 860,302 | $294K | No change |
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | 546,442 | $277K | Reduce -28.7% |
| AMODW Insight Acquisition Co. -CW23 | *W EXP 12/13/202 | 1,854,665 | $202K | No change |
| BKSYW Blacksky Technology -CW24 | *W EXP 09/09/202 | 350,000 | $103K | No change |
| OPTXW Omnilit Acquisition Class A -23 | *W EXP 99/99/999 | 803,132 | $70K | No change |
| DAVEW Dave Inc. -CW27 | *W EXP 01/05/202 | 28,750 | $52K | No change |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | 1,666,808 | $50K | No change |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | 175,000 | $33K | New |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | 400,000 | $20K | No change |
| DAICW Cid Holdco Inc. -26 | *W EXP 12/31/202 | 300,000 | $20K | New |
| BTMWQ Bitcoin Depot Inc.-CW23 | *W EXP 06/30/202 | 50,000 | $20K | No change |
| ZEOWW Esgen Acquisition A -CW23 | *W EXP 03/13/202 | 250,000 | $16K | No change |
| TVGNW Semper Paratus Acqu -CW26 | *W EXP 02/14/202 | 200,000 | $14K | No change |
| LIMNW Liminatus Pharma Inc. Class A-28 | *W EXP 04/30/203 | 50,000 | $12K | New |
| RDZNW Vahanna Tech Edge -CW24 | *W EXP 11/30/202 | 225,000 | $11K | No change |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | 200,000 | $10K | No change |
| PGYWW Pagaya Technologies Ltd. -27 | *W EXP 99/99/999 | 48,661 | $8K | No change |
| BDMDW Baird Medical Investment -28 | *W EXP 10/01/202 | 100,000 | $8K | No change |
| CEROW Phoenix Biotech Acq -CW26 | *W EXP 02/13/202 | 224,930 | $5K | No change |
| BSLKW Golden Arrow Merger A -CW26 | *W EXP 08/13/202 | 166,666 | $4K | No change |
| MLKWF Waldencast Acq Class A -CW27 | *W EXP 07/27/202 | 33,333 | $3K | No change |
| KPLTW Katapult Holdings Inc. -CW26 | *W EXP 06/09/202 | 400,000 | $3K | No change |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 02/14/203 | 50,000 | $2K | No change |
| XBPEW CF Acquisition Viii A -CW27 | *W EXP 11/30/202 | 24,778 | $1K | No change |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | 16,666 | $447 | No change |
Total filed on the 13F, all lines: $309.9M.
Portfolio Sells Q1 2025 → Q2 2025
| TQQQ Proshares Ultrapro QQQ | Sold out | 0.00% | −3.24 |
| HLLY Holley Inc. | Reduce -22.7% | 2.67% | −1.75 |
| CNDT Conduent Inc. | Reduce -21.8% | 3.82% | −1.16 |
| ETWO E2OPEN Parent Holdings Inc. | Sold out | 0.00% | −1.07 |
| KROS Keros Therapeutics Inc. | Sold out | 0.00% | −0.88 |
| CMPS Compass Pathways PLC | Reduce -79.8% | 0.21% | −0.84 |
| ELDN Eledon Pharmaceuticals Inc. | Reduce -26.9% | 1.17% | −0.83 |
| NN Nextnav Inc. | Sold out | 0.00% | −0.78 |
| GATE Marblegate Acquisition Cor-A | Sold out | 0.00% | −0.44 |
| PVLA Palvella Therapeutics Inc. | Reduce -10.7% | 0.92% | −0.35 |
| INZY Inozyme Pharma Inc. | Sold out | 0.00% | −0.32 |
| GOCOQ Gohealth Inc. Class A | Sold out | 0.00% | −0.22 |
| CVEO Civeo Corp. | Reduce -8.8% | 2.38% | −0.21 |
| IRON Disc Medicine Inc. | Reduce -12.8% | 2.10% | −0.15 |
| CGEM Cullinan Therapeutics Inc. | Reduce -2.0% | 5.83% | −0.13 |
| ROIV Roivant Sciences Ltd. | Sold out | 0.00% | −0.13 |
| CRML Critical Metals Corp. | Sold out | 0.00% | −0.03 |
| TRML Tourmaline Bio Inc. | Reduce -3.9% | 5.17% | +0.07 |
| EYPT Eyepoint Inc. | Reduce -29.5% | 1.72% | +0.32 |
| CMPX Compass Therapeutics Inc. | Reduce -12.3% | 2.19% | +0.37 |
| TNGX Tango Therapeutics Inc. | Reduce -61.6% | 1.35% | +0.41 |
Portfolio Buys Q1 2025 → Q2 2025
| TEM Tempus AI Inc. Class A | New | 1.65% | +1.65 |
| LRMR Larimar Therapeutics Inc. | Add +3.1% | 4.62% | +1.30 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +66.6% | 3.01% | +1.22 |
| STWD Starwood Property Trust Inc. | New | 0.86% | +0.86 |
| DELL Dell Technologies -C | New | 0.83% | +0.83 |
| BMEA Biomea Fusion Inc. | New | 0.76% | +0.76 |
| FLD Fold Holdings Inc. | New | 0.62% | +0.62 |
| CABA Cabaletta Bio Inc. | New | 0.55% | +0.55 |
| KRRO Korro Bio Inc. | New | 0.51% | +0.51 |
| APGE Apogee Therapeutics Inc. | New | 0.49% | +0.49 |
| MLYS Mineralys Therapeutics Inc. | Add +62.9% | 1.47% | +0.42 |
| TTAN Servicetitan Inc. Class A | New | 0.39% | +0.39 |
| CNTX Context Therapeutics Inc. | Add +0.5% | 1.57% | +0.12 |
| KPLT Katapult Holdings Inc. | New | 0.00% | +0.00 |
| CNTA Centessa Pharmaceuticals Ltd. | Add +5.0% | 1.41% | −0.06 |
| ENGN Engene Holdings Inc. | Add +13.7% | 4.40% | −0.35 |
Notes & Other Activity Q1 2025 → Q2 2025
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | Reduce -21.0% | 476,685 | $381K |
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | Reduce -28.7% | 546,442 | $277K |
| GATEW Marblegate Acquisition -CW22 | *W EXP 08/31/202 | Sold out | 597,333 | $96Kbefore exit |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | New | 175,000 | $33K |
| DAICW Cid Holdco Inc. -26 | *W EXP 12/31/202 | New | 300,000 | $20K |
| ZAPWF Zapp Electric Vehicles -28 | *W EXP 99/99/999 | Sold out | 1,930,986 | $19Kbefore exit |
| LIMNW Liminatus Pharma Inc. Class A-28 | *W EXP 04/30/203 | New | 50,000 | $12K |
| PITWF Heramba Electric PLC-28 | *W EXP 07/26/202 | Sold out | 989,998 | $10Kbefore exit |
| VSTWF Vast Solar PTY Ltd. -28 | *W EXP 07/01/202 | Sold out | 200,000 | $6Kbefore exit |
| ZCARW Zoomcar Holdings Inc. | *W EXP 05/31/202 | Sold out | 250,000 | $3Kbefore exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 48 | $656.7M | SPCX, AKTS, CGEM, LRMR, NCDL |
| Q1 2026 | 54 | $369.9M | AKTS, LRMR, ENGN, NCDL, CGEM |
| Q4 2025Amended | 50 | $320.9M | ENGN, NCDL, OBDC, LRMR, CGEM |
| Q3 2025 | 46 | $319.9M | NCDL, OBDC, ENGN, LRMR, EVCM |
| Q2 2025 | 46 | $308.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q1 2025 | 45 | $309.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q4 2024 | 48 | $432.6M | NCDL, KVYO, PLRX, OBDC, CGEM |
| Q3 2024 | 68 | $514.6M | NCDL, KVYO, TRML, PLRX, CGEM |
| Q2 2024 | 40 | $359.5M | CGEM, PLRX, OBDC, KVYO, LRMR |
| Q1 2024 | 44 | $500.6M | HOOD, CGEM, PLRX, ENGN, TRML |